Last reviewed · How we verify

NCT06700772

Histomorphometric and Radiographic Evaluation of Bone Following Maxillary Sinus Augmentation

Recruiting now Phase 1 Last updated 22 November 2024
What this trial tests

Phase 1 trial testing mixing bone marrow aspirate concentrate from maxillary tuberosity with bovine bone in Sinus Floor Elevation in 26 participants. Currently enrolling.

Timeline
1 December 2024
Primary endpoint
1 December 2025
1 December 2025

Quick facts

Lead sponsorCairo University
PhasePhase 1
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment26
Start date1 December 2024
Primary completion1 December 2025
Estimated completion1 December 2025
Sites2 locations across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 20 to 50, any sex, with Sinus Floor Elevation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Two groups of patients with posterior vertical deficient maxillary alveolar ridge with pneumatized sinus and needing dental implant . First group will be subjected to open sinus lifting using autogenous bone mixed with bone marrow aspirate concentrate cells from maxillary tuberosity and the second group will be subjected to open sinus lifting using autogenous bone mixed with bovine bone

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06700772.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing